uLabs
Ultrasonic Point-of-care Testing System
Health Tech & Life Sciences
Non Active, Aug 2020 ceased to operate
Company Overview
Snapshot
Founded in January 2018 by Misha Pakanayev-Halevi, uLabs operates with 1–10 employees. The company ceased operations in August 2020.
Business overview
uLabs develops an ultrasonic technology for next-generation point-of-care (POC) testing systems, enabling accurate real-time measurement of biological fluids and tissues. Its initial handheld system is designed for clinical applications in hospitals, offering an alternative to central laboratories for samples like blood, plasma, and urine. The technology focuses on real-time ultrasonic lab testing to track electrolytes, biopolymers, and vital signs, serving the Health Tech & Life Sciences sector, specifically Digital Medical Diagnostics.
Company Intelligence Q&A
- What is uLabs' primary focus?
- uLabs focuses on developing an ultrasonic technology for next-generation point-of-care (POC) testing systems, enabling accurate real-time measurement of biological fluids and tissues.
- When was uLabs founded?
- uLabs was founded in January 2018.
- Who is a co-founder of uLabs?
- Misha Pakanayev-Halevi is a co-founder and CEO of uLabs.
- What markets does uLabs target with its technology?
- uLabs targets markets including Israel, Europe, the Americas, and China with its ultrasonic point-of-care testing system.
- What is the operational status of uLabs?
- uLabs ceased to operate in August 2020.